Literature DB >> 23661723

Quantifying options for reducing coronary heart disease mortality by 2020.

Mark D Huffman1, Donald M Lloyd-Jones, Hongyan Ning, Darwin R Labarthe, Maria Guzman Castillo, Martin O'Flaherty, Earl S Ford, Simon Capewell.   

Abstract

BACKGROUND: The American Heart Association (AHA) 2020 Strategic Impact Goal proposes a 20% improvement in cardiovascular health of all Americans. We aimed to estimate the potential reduction in coronary heart disease (CHD) deaths. METHODS AND
RESULTS: We used data on 40 373 adults free of cardiovascular disease from the National Health and Nutrition Examination Survey (NHANES; 1988-2010). We quantified recent trends for 6 metrics (total cholesterol, systolic blood pressure, physical inactivity, smoking, diabetes mellitus, and obesity) and generated linear projections to 2020. We projected the expected number of CHD deaths in 2020 if 2006 age- and sex-specific CHD death rates remained constant, which would result in ≈480 000 CHD deaths in 2020 (12% increase). We used the previously validated IMPACT CHD model to project numbers of CHD deaths in 2020 under 2 different scenarios: (1) Assuming a 20% improvement in each cardiovascular health metric, we project 365 000 CHD deaths in 2020 (range 327 000-403 000) a 24% decrease reflecting modest reductions in total cholesterol (-41 000), systolic blood pressure (-36 000), physical inactivity (-12 000), smoking (-10 000), diabetes mellitus (-10 000), and obesity (-5000); (2) Assuming that recent risk factor trends continue to 2020, we project 335 000 CHD deaths (range 274 000-386 000), a 30% decrease reflecting improvements in total cholesterol, systolic blood pressure, smoking, and physical activity (≈167 000 fewer deaths), offset by increases in diabetes mellitus and body mass index (≈24 000 more deaths).
CONCLUSIONS: Two contrasting scenarios of change in cardiovascular health metrics could prevent 24% to 30% of the CHD deaths expected in 2020, though with differing effects by age. Unfavorable continuing trends in obesity and diabetes mellitus would have substantial adverse effects. This analysis demonstrates the utility of modelling to inform health policy.

Entities:  

Keywords:  American Heart Association; epidemiology; heart diseases; risk factors

Mesh:

Year:  2013        PMID: 23661723      PMCID: PMC3795417          DOI: 10.1161/CIRCULATIONAHA.112.000769

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

1.  Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.

Authors:  J Stamler; R Stamler; J D Neaton; D Wentworth; M L Daviglus; D Garside; A R Dyer; K Liu; P Greenland
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment.

Authors:  M G Hunink; L Goldman; A N Tosteson; M A Mittleman; P A Goldman; L W Williams; J Tsevat; M C Weinstein
Journal:  JAMA       Date:  1997-02-19       Impact factor: 56.272

Review 3.  Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis.

Authors:  A Briggs; M Sculpher; M Buxton
Journal:  Health Econ       Date:  1994 Mar-Apr       Impact factor: 3.046

4.  Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study.

Authors:  Chuanhui Dong; Tatjana Rundek; Clinton B Wright; Zane Anwar; Mitchell S V Elkind; Ralph L Sacco
Journal:  Circulation       Date:  2012-05-22       Impact factor: 29.690

5.  Small changes in United Kingdom cardiovascular risk factors could halve coronary heart disease mortality.

Authors:  Belgin Unal; Julia A Critchley; Simon Capewell
Journal:  J Clin Epidemiol       Date:  2005-04-18       Impact factor: 6.437

6.  Primary prevention of coronary heart disease in women through diet and lifestyle.

Authors:  M J Stampfer; F B Hu; J E Manson; E B Rimm; W C Willett
Journal:  N Engl J Med       Date:  2000-07-06       Impact factor: 91.245

7.  Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys.

Authors:  Mark D Huffman; Simon Capewell; Hongyan Ning; Christina M Shay; Earl S Ford; Donald M Lloyd-Jones
Journal:  Circulation       Date:  2012-04-30       Impact factor: 29.690

8.  Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels.

Authors:  J A Critchley; S Capewell
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

9.  Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland.

Authors:  E Vartiainen; P Puska; J Pekkanen; J Tuomilehto; P Jousilahti
Journal:  BMJ       Date:  1994-07-02

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  25 in total

Review 1.  Polychlorinated biphenyls and links to cardiovascular disease.

Authors:  Jordan T Perkins; Michael C Petriello; Bradley J Newsome; Bernhard Hennig
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-17       Impact factor: 4.223

2.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 3.  Cardiovascular risk assessment: a global perspective.

Authors:  Dong Zhao; Jing Liu; Wuxiang Xie; Yue Qi
Journal:  Nat Rev Cardiol       Date:  2015-03-10       Impact factor: 32.419

Review 4.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

5.  Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?

Authors:  Jesse D Ortendahl; Allison L Diamant; Peter P Toth; Dasha Cherepanov; Amanda L Harmon; Michael S Broder
Journal:  Clin Cardiol       Date:  2018-11-28       Impact factor: 2.882

6.  The effects of percutaneous transluminal coronary intervention on biomarkers of oxidative stress in the erythrocytes of elderly male patients.

Authors:  Karolina Szewczyk-Golec; Paweł Grzelakowski; Tomasz Ługowski; Józef Kędziora
Journal:  Redox Rep       Date:  2016-11-20       Impact factor: 4.412

7.  Biopsychosocial health disparities among young women enrolled in cardiac rehabilitation.

Authors:  Theresa M Beckie; Gerald Fletcher; Maureen W Groer; Kevin E Kip; Ming Ji
Journal:  J Cardiopulm Rehabil Prev       Date:  2015 Mar-Apr       Impact factor: 2.081

8.  Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.

Authors:  Reza Mohebi; Chen Chen; Nasrien E Ibrahim; Cian P McCarthy; Hanna K Gaggin; Daniel E Singer; Emily P Hyle; Jason H Wasfy; James L Januzzi
Journal:  J Am Coll Cardiol       Date:  2022-08-09       Impact factor: 27.203

9.  Validating a bimodal intravascular ultrasound (IVUS) and near-infrared fluorescence (NIRF) catheter for atherosclerotic plaque detection in rabbits.

Authors:  Maxime Abran; Barbara E Stähli; Nolwenn Merlet; Teodora Mihalache-Avram; Mélanie Mecteau; Eric Rhéaume; David Busseuil; Jean-Claude Tardif; Frédéric Lesage
Journal:  Biomed Opt Express       Date:  2015-09-14       Impact factor: 3.732

10.  Modeling Future Cardiovascular Disease Mortality in the United States: National Trends and Racial and Ethnic Disparities.

Authors:  Jonathan Pearson-Stuttard; Maria Guzman-Castillo; Jose L Penalvo; Colin D Rehm; Ashkan Afshin; Goodarz Danaei; Chris Kypridemos; Tom Gaziano; Dariush Mozaffarian; Simon Capewell; Martin O'Flaherty
Journal:  Circulation       Date:  2016-02-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.